Qureight
PrivateLast Round
Series B
Jul 29, 2026
Total Funding Raised
$31.23M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Qureight operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Series B round in July 2026.
Qureight is a biotechnology company that provides an AI-powered clinical data curation and analytics platform to accelerate drug development for lung and heart diseases.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical Imaging, Medical AI, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qureight Comparables
Compare Qureight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thirona | 85% | |
| Image Analysis Group | 84% | |
| QMENTA | 82% |
For institutional investors. Book with your work email.
Qureight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 29, 2026 | ||||
| Series A | Apr 16, 2024 | ||||
| Seed | Feb 3, 2022 | ||||
| Seed | Sep 24, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Qureight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascension Ventures | Series A, Series B, Seed |
| Playfair Capital | Series A, Seed |
| Canaccord Genuity Wealth Management | Series B, Series A |
| Cambridge Angels | Series A, Seed |
| Meltwind Advisory | Series A, Series B, Seed |
| CMS Ventures | Series A, Seed |
| Hargreave Hale AIM VCT | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2026
Grew 17% QoQ, from 53 to 62 employees.
- Jul 29, 2026
$20M round led by Molten Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardOct 23, 2026
Qureight receives the Most Impactful CRO Award, sponsored by Gallagher, for its work as an end-to-end imaging CRO providing enterprise-grade imaging and precision endpoints for clinical trials focused on lung and heart disease.
- signs_new_clientOct 20, 2026
On Oct 20th '26 in United Kingdom, Celea Therapeutics, Inc. selects and contracts Qureight as the end-to-end imaging CRO for its Phase 3 SURPASS-IPF trial, including Fibr8(TM) and four additional AI imaging models.
- expands_offices_toAug 19, 2026
Qureight opens its second site in London on Aug 19th '26 to access machine learning, commercial and clinical operations talent that complements its Cambridge headquarters workforce.
For institutional investors. Book with your work email.
Qureight Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Qureight's valuation, stock price, and market status.
Is Qureight a public or private company?
Qureight is a private company.
What is the current stock price of Qureight?
Qureight is a private company, so its shares have no public market price. Caplight tracks Qureight's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qureight worth (valuation)?
Valuation information for Qureight is not publicly available.
Can I buy Qureight stock?
Qureight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qureight's last funding round?
Qureight's most recent funding round was Series B on July 29, 2026.
Who are the main investors in Qureight?
Key investors in Qureight include Playfair Capital, Canaccord Genuity Wealth Management, Hargreave Hale AIM VCT, Molten Ventures.
Will Qureight IPO soon?
No public IPO plans have been announced for Qureight.
How can I track Qureight secondary market activity?
Caplight tracks bids, offers, and trades in Qureight's shares on secondary markets.